A tool to evaluate potential transplant candidates that looks at tumor marker levels in the blood can help predict which liver cancer patients are most likely to have their disease remain under control after receiving a transplant, according to a new study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian.
Two gene variants found in African American women may explain why they are more likely to be diagnosed with triple negative breast cancer (TNBC) than white women of European ancestry, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.
The heart damage seen in many severely ill COVID-19 patients results in part from infection-activated immune cells called macrophages, which infiltrate the heart and secrete cell-damaging chemicals, according to a study co-led by researchers at Weill Cornell Medicine, NewYork-Presbyterian, Icahn School of Medicine at Mount Sinai and Columbia University Irving Medical Center.
In early March, Dr. Shetal Shah, MD ’00, was in Albany along with other doctors to lobby for important regulations to protect children’s health. As president of New York State Chapter 2 of the American Academy of Pediatrics, Dr. Shah had been there many times before, including last summer as the state grappled with the largest measles outbreak in decades.
